Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 48.00
High: 48.00
Low: 48.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Offer for Subscription

22 Sep 2017 18:25

RNS Number : 6312R
Maven Income & Growth VCT 4 PLC
22 September 2017
 

Joint Announcement

 

Offer for Subscription

 

22 September 2017

The board of directors of Maven Income and Growth VCT 3 PLC ("Maven VCT 3") and Maven Income and Growth VCT 4 PLC ("Maven VCT 4") (together the "Companies" and each a "Company") are pleased to announce that they have published a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription for new Ordinary Shares of 10p each in the Companies to raise, in aggregate, up to £30 million with over-allotment facilities of up to, in aggregate, a further £10 million (before issue costs) (the "Offers").

 

The Companies have also published a joint circular (the "Circular") seeking the approval of their respective shareholders for matters in connection with the Offers, each Company giving notice of a general meeting to be held on 8 November 2017 (the "General Meeting").

 

The Offers will open on 22 September 2017 and are expected to close no later than 3 April 2018 in relation to the tax year 2017/18 and on 20 April 2017 in relation to the tax year 2018/19 (unless the relevant Offer is fully subscribed by an earlier date or previously extended by the relevant board to no later than 14 September 2018).

 

Each Offer is conditional on the passing of all the resolutions at the relevant General Meeting.

Pursuant to individual offer agreements dated 22 September 2017 relating to each Offer between, among others, each relevant Company and Maven Capital Partners LLP ("Maven"), Maven, as the administrator of the Offer, will receive an offer administration fee of 2.5% of the application amount in relation to each accepted application, with reductions to the fee applying in certain cases (for instance, early applications under the Offers). Maven as the investment manager of each Company is a related party of each Company under the Listing Rules, and the payment of such a fee by the Company to Maven is a transaction to which Listing Rule 11.1.10R applies.

Further, William Nixon has expressed his intention, prior to the close of each of the Offers, to subscribe £50,000 in Maven VCT 3 and £50,000 in Maven VCT 4 under the relevant Offer. As a director of each of the Companies, William Nixon is a related party of the relevant Company under the Listing Rules and consequently each subscription is a transaction to which Listing Rule 11.1.10R applies.

Maven VCT 3 has also agreed with Maven that with effect from 1 December 2017 Maven will also be entitled to a performance incentive fee, for each six month period ending 31 May and 30 November, of an amount equal to 15% of any increase in the total return (before applying any performance incentive fee) as at the end of the relevant six month period to the total return (after accruing for the performance incentive fee payable for that period) compared to the end of the last six month period on which a performance incentive fee was paid. Payments in relation to any performance incentive fee shall not exceed £890,000 in relation to any rolling twelve month period ending on the date of the proposed payment. Maven and Maven VCT 3 have also agreed to vary the terms of a co-investment agreement (which enables employees and officers of Maven to co-invest with Maven VCT 3 in certain new and follow-on investments) with the effect that the 8% total investment limit (which applies to the investments that can be made by such employees and officers) will be reduced to 5% with effect from 1 December 2017. As Maven is a related party of Maven VCT 3 under the Listing Rules, the introduction of a performance incentive fee payable by that Company to Maven, together with the variation of the co-investment arrangements, are transactions to which Listing Rule 11.1.10R applies.

To obtain a copy of the Securities Note, private investors and financial advisers should call Maven Capital Partners LLP on 0141 306 7400. A downloadable version of the Securities Note will also be available from the each of the Company's websites: http://www.mavencp.com/migvct3 and http://www.mavencp.com/migvct4 .

 

Copies of the Prospectus and Circular are available, free of charge, from Maven Capital Partners UK LLP at Kintyre House, 205 West George Street, Glasgow G2 2LW.

 

In accordance with the Listing Rules, the Prospectus and Circular have been submitted to the National Storage Mechanism and will shortly be available for inspection at:

 

www.morningstar.co.uk/uk/NSM.

 

Any enquiries in respect of the Offers should be directed to:

Maven Capital Partners UK LLP

Telephone: 0141 306 7400E-mail: enquiries@mavencp.com

Maven Capital Partners UK LLPSecretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRPGUWPBUPMGMP
Date   Source Headline
4th May 20113:24 pmRNSIssue of Equity
14th Apr 20115:44 pmRNSDirector/PDMR Shareholding
6th Apr 20112:28 pmRNSDirector/PDMR Shareholding
6th Apr 20112:27 pmRNSDirector/PDMR Shareholding
6th Apr 20119:31 amRNSIssue of Equity
8th Mar 20119:42 amRNSDirector/PDMR Shareholding
8th Mar 20119:32 amRNSDirector/PDMR Shareholding
2nd Mar 20119:54 amRNSTotal Voting Rights
1st Mar 20114:01 pmRNSAnnual Financial Report
2nd Feb 20114:12 pmRNSIssue of Equity
18th Nov 20102:43 pmRNSDirector/PDMR Shareholding
18th Nov 20102:00 pmRNSStatement re Linked Offer for Subscription
18th Nov 20101:18 pmRNSTransaction in Own Shares
3rd Nov 201011:10 amRNSDirector/PDMR Shareholding
20th Oct 20103:58 pmRNSStatement re Cancellation of Share Premium Account
20th Oct 20103:58 pmRNSStatement re Cancellation of Share Premium Account
14th Oct 20103:02 pmRNSInterim Management Statement
1st Sep 20103:22 pmRNSResult of EGM
6th Aug 20102:26 pmRNSCirc re. cancellation of share premium
9th Jul 20104:37 pmRNSHalf Yearly Report
28th May 20104:21 pmRNSTransaction in Own Shares
20th May 20109:05 amRNSTransaction in Own Shares
12th May 20109:16 amRNSInterim Management Statement
10th May 201011:21 amRNSTotal Voting Rights
7th May 201011:58 amRNSTransaction in Own Shares
7th May 20109:35 amRNSResult of AGM
4th May 20102:43 pmRNSIssue of Equity
30th Apr 201011:09 amRNSAnnual Information Update
6th Apr 201011:19 amRNSIssue of Equity
1st Apr 20105:24 pmRNSIssue of Equity
8th Mar 20105:53 pmRNSAnnual Financial Report
26th Jan 201011:15 amRNSLinked Offer for Subscription
26th Jan 201011:15 amRNSLinked Offer for Subscription
26th Jan 201011:15 amRNSLinked Offer for Subscription
26th Jan 201011:15 amRNSLinked Offer for Subscription
5th Jan 201011:14 amRNSTotal Voting Rights
14th Dec 20099:59 amRNSChange of Name
7th Dec 200911:03 amRNSTransaction in Own Shares
26th Nov 200912:18 pmRNSResult of EGM
2nd Nov 20094:34 pmRNSChange of Adviser
30th Oct 20093:47 pmRNSNotice of EGM
16th Oct 200912:09 pmRNSInterim Management Statement
1st Sep 20099:39 amRNSTotal Voting Rights
3rd Aug 20093:53 pmRNSTransaction in Own Shares
27th Jul 20093:31 pmRNSCorrection to record date
24th Jul 20094:48 pmRNSHalf Yearly Report
10th Jun 200911:48 amRNSChange of Adviser
9th Apr 20093:55 pmRNSAGM Statement
9th Apr 20091:06 pmRNSInterim Management Statement
6th Apr 20092:57 pmRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.